Biotechnology
The Biotechnology industry has a total of 602 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.66 billion.
Market Cap
1.12T
Revenue
105.66B
Profits
-42.08B
PE Ratio
n/a
Profit Margin
-39.83%
Dividend Yield
0.04%
602 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.26B | 4.17% | 1,621,122 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.61B | 2.46% | 671,660 | 14.34B |
| 3 | ARGX | argenx SE | 50.29B | -1.08% | 375,241 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.35B | -0.93% | 1,476,915 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 39.16B | 1.99% | 267,585 | 4.97B |
| 6 | INSM | Insmed Incorporated | 31.96B | -0.77% | 2,629,309 | 447.02M |
| 7 | BNTX | BioNTech SE | 26.75B | 1.02% | 633,315 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 25.77B | 1.25% | 3,535,231 | 2.35B |
| 9 | INCY | Incyte Corporation | 21.28B | 5.48% | 2,193,911 | 4.81B |
| 10 | GMAB | Genmab A/S | 19.08B | -0.23% | 1,760,221 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 18.85B | 1.39% | 2,135,115 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 18.48B | 22.14% | 24,051,861 | 13.31M |
| 13 | MRNA | Moderna, Inc. | 16.02B | 0.34% | 8,338,373 | 2.23B |
| 14 | IONS | Ionis Pharmaceuticals, Inc. | 14.01B | 3.62% | 1,837,287 | 966.96M |
| 15 | ASND | Ascendis Pharma A/S | 13.64B | 2.19% | 805,326 | 758.59M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.11B | 6.78% | 4,575,539 | 353.78M |
| 17 | EXEL | Exelixis, Inc. | 11.82B | 3.61% | 3,364,656 | 2.29B |
| 18 | SMMT | Summit Therapeutics Inc. | 11.56B | 8.23% | 2,708,912 | - |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 11.17B | 1.71% | 1,640,069 | 3.09B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.98B | 0.11% | 2,775,027 | 20.87M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.85B | 3.06% | 338,614 | 740.64M |
| 22 | TECH | Bio-Techne Corporation | 10.45B | 1.40% | 1,546,951 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.06B | 1.44% | 703,276 | 4.16B |
| 24 | HALO | Halozyme Therapeutics, Inc. | 9.55B | 3.58% | 2,245,404 | 1.24B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.20B | 0.95% | 661,333 | 561.26M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.03B | -0.19% | 23,689,339 | 1.09B |
| 27 | ABVX | ABIVAX Société Anonyme | 8.91B | 6.29% | 672,789 | 6.23M |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 8.86B | 4.56% | 450,814 | 7.46M |
| 29 | PCVX | Vaxcyte, Inc. | 8.06B | 4.16% | 1,080,778 | - |
| 30 | NUVL | Nuvalent, Inc. | 8.04B | 2.67% | 566,516 | - |
| 31 | KRYS | Krystal Biotech, Inc. | 7.91B | 1.91% | 313,241 | 373.16M |
| 32 | CYTK | Cytokinetics, Incorporated | 7.62B | 3.49% | 1,760,018 | 87.21M |
| 33 | BLTE | Belite Bio, Inc | 7.05B | 5.34% | 364,681 | - |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.91B | -0.25% | 1,034,856 | 174.33M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.37B | 4.81% | 594,687 | 43.74M |
| 36 | CAI | Caris Life Sciences, Inc. | 6.21B | 3.53% | 1,682,518 | 649.06M |
| 37 | MIRM | Mirum Pharmaceuticals, Inc. | 6.02B | 2.28% | 568,476 | 471.79M |
| 38 | PTCT | PTC Therapeutics, Inc. | 6.00B | 3.21% | 1,040,458 | 1.78B |
| 39 | IBRX | ImmunityBio, Inc. | 5.96B | 7.27% | 18,255,907 | 82.56M |
| 40 | COGT | Cogent Biosciences, Inc. | 5.64B | 3.87% | 1,771,761 | - |
| 41 | IMVT | Immunovant, Inc. | 5.51B | 12.43% | 3,313,237 | - |
| 42 | PTGX | Protagonist Therapeutics, Inc. | 5.28B | 4.74% | 812,792 | 209.22M |
| 43 | GPCR | Structure Therapeutics Inc. | 5.18B | 2.34% | 1,101,916 | - |
| 44 | CELC | Celcuity Inc. | 4.94B | 2.37% | 638,008 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 4.86B | 7.13% | 1,201,309 | - |
| 46 | CRSP | CRISPR Therapeutics AG | 4.64B | 6.23% | 1,669,489 | 38.34M |
| 47 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.64B | 1.09% | 1,996,767 | 1.54M |
| 48 | FOLD | Amicus Therapeutics, Inc. | 4.49B | 0.14% | 24,424,623 | 598.70M |
| 49 | CORT | Corcept Therapeutics Incorporated | 4.29B | 6.44% | 1,309,621 | 741.17M |
| 50 | TGTX | TG Therapeutics, Inc. | 4.22B | 3.96% | 1,622,166 | 531.90M |
| 51 | APGE | Apogee Therapeutics, Inc. | 4.20B | 0.18% | 1,354,621 | - |
| 52 | TERN | Terns Pharmaceuticals, Inc. | 4.11B | 6.88% | 1,246,129 | - |
| 53 | CGON | CG Oncology, Inc. | 4.06B | 2.36% | 841,664 | 2.17M |
| 54 | ACAD | ACADIA Pharmaceuticals Inc. | 3.99B | 0.43% | 2,355,607 | 1.05B |
| 55 | ACLX | Arcellx, Inc. | 3.93B | 1.73% | 575,241 | 35.90M |
| 56 | ADMA | ADMA Biologics, Inc. | 3.91B | 3.07% | 1,588,542 | 488.56M |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 3.89B | 6.99% | 537,092 | 35.24M |
| 58 | ERAS | Erasca, Inc. | 3.80B | 3.45% | 4,304,723 | - |
| 59 | LGND | Ligand Pharmaceuticals Incorporated | 3.75B | -0.65% | 272,766 | 251.23M |
| 60 | LQDA | Liquidia Corporation | 3.74B | 3.56% | 1,504,065 | 69.22M |
| 61 | CNTA | Centessa Pharmaceuticals plc | 3.43B | -0.21% | 916,750 | 15.00M |
| 62 | ARQT | Arcutis Biotherapeutics, Inc. | 3.35B | 4.79% | 1,362,899 | 317.93M |
| 63 | DNLI | Denali Therapeutics Inc. | 3.29B | 5.29% | 1,648,322 | - |
| 64 | ALMS | Alumis Inc. | 3.26B | -0.57% | 1,463,150 | 22.12M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.21B | 8.18% | 3,694,237 | - |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.20B | 2.55% | 611,414 | 7.50M |
| 67 | LEGN | Legend Biotech Corporation | 3.16B | 2.40% | 2,546,252 | 909.05M |
| 68 | VERA | Vera Therapeutics, Inc. | 3.09B | 6.23% | 1,039,089 | - |
| 69 | EWTX | Edgewise Therapeutics, Inc. | 3.08B | 7.02% | 918,301 | - |
| 70 | IRON | Disc Medicine, Inc. | 3.01B | 1.77% | 463,088 | - |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.00B | 2.22% | 1,030,711 | 578.20M |
| 72 | APLS | Apellis Pharmaceuticals, Inc. | 2.97B | 4.03% | 1,824,965 | 1.02B |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 2.82B | 1.26% | 985,253 | 214.83M |
| 74 | VRDN | Viridian Therapeutics, Inc. | 2.79B | 0.27% | 1,940,324 | 70.79M |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.77B | 1.51% | 1,422,083 | - |
| 76 | IMNM | Immunome, Inc. | 2.75B | 3.67% | 1,138,396 | 9.68M |
| 77 | TARS | Tarsus Pharmaceuticals, Inc. | 2.74B | 4.24% | 799,487 | 366.10M |
| 78 | SYRE | Spyre Therapeutics, Inc. | 2.73B | 6.62% | 787,313 | - |
| 79 | TVTX | Travere Therapeutics, Inc. | 2.66B | 0.81% | 1,313,990 | 435.83M |
| 80 | BEAM | Beam Therapeutics Inc. | 2.62B | 7.24% | 1,347,587 | 55.70M |
| 81 | RCUS | Arcus Biosciences, Inc. | 2.60B | 4.99% | 833,112 | 240.00M |
| 82 | WVE | Wave Life Sciences Ltd. | 2.46B | 5.49% | 2,730,080 | 109.23M |
| 83 | ADPT | Adaptive Biotechnologies Corporation | 2.43B | -4.25% | 4,140,282 | 276.98M |
| 84 | RARE | Ultragenyx Pharmaceutical Inc. | 2.38B | 3.83% | 2,679,699 | 630.60M |
| 85 | MLYS | Mineralys Therapeutics, Inc. | 2.36B | 5.53% | 1,580,753 | - |
| 86 | TLX | Telix Pharmaceuticals Limited | 2.34B | 2.01% | 179,440 | 664.23M |
| 87 | SLNO | Soleno Therapeutics, Inc. | 2.23B | 4.93% | 1,458,812 | 98.68M |
| 88 | AAPG | Ascentage Pharma Group International | 2.21B | 1.36% | 1,637 | 54.52M |
| 89 | GLPG | Galapagos NV | 2.19B | -0.06% | 71,192 | 336.64M |
| 90 | DNTH | Dianthus Therapeutics, Inc. | 2.19B | 8.95% | 719,729 | 3.08M |
| 91 | MAZE | Maze Therapeutics, Inc. | 2.17B | 2.72% | 663,236 | 2.50M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.15B | 2.36% | 516,602 | 825.94M |
| 93 | RXRX | Recursion Pharmaceuticals, Inc. | 2.07B | 11.80% | 26,271,822 | 43.69M |
| 94 | MESO | Mesoblast Limited | 2.02B | -0.81% | 283,952 | 17.20M |
| 95 | ZLAB | Zai Lab Limited | 2.02B | 6.01% | 650,009 | 441.63M |
| 96 | OLMA | Olema Pharmaceuticals, Inc. | 1.99B | 1.40% | 962,217 | - |
| 97 | OCUL | Ocular Therapeutix, Inc. | 1.99B | 2.81% | 4,095,002 | 51.95M |
| 98 | NUVB | Nuvation Bio Inc. | 1.95B | 1.42% | 6,339,232 | 26.75M |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 1.94B | 8.63% | 3,173,580 | 2.41B |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.90B | 1.26% | 886,584 | 265.81M |
| 101 | STOK | Stoke Therapeutics, Inc. | 1.85B | 6.30% | 1,014,703 | 205.63M |
| 102 | VCEL | Vericel Corporation | 1.83B | 2.29% | 498,888 | 258.72M |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 1.83B | 4.27% | 1,480,957 | 111.30M |
| 104 | RAPT | RAPT Therapeutics, Inc. | 1.78B | 0.02% | 3,587,861 | - |
| 105 | ARDX | Ardelyx, Inc. | 1.78B | 4.57% | 3,183,737 | 398.23M |
| 106 | MNKD | MannKind Corporation | 1.77B | 4.90% | 3,012,568 | 313.79M |
| 107 | ELVN | Enliven Therapeutics, Inc. | 1.75B | 9.00% | 1,076,222 | - |
| 108 | NRIX | Nurix Therapeutics, Inc. | 1.73B | 5.64% | 836,540 | 83.98M |
| 109 | PHVS | Pharvaris N.V. | 1.72B | 5.09% | 127,912 | - |
| 110 | CRVS | Corvus Pharmaceuticals, Inc. | 1.71B | 7.35% | 1,708,080 | - |
| 111 | ZYME | Zymeworks Inc. | 1.70B | 3.18% | 575,661 | 134.48M |
| 112 | MBX | MBX Biosciences, Inc. | 1.69B | 4.49% | 343,765 | - |
| 113 | TNGX | Tango Therapeutics, Inc. | 1.68B | 4.69% | 2,508,356 | 66.50M |
| 114 | DFTX | Definium Therapeutics, Inc. | 1.66B | 4.00% | 1,172,450 | - |
| 115 | TYRA | Tyra Biosciences, Inc. | 1.65B | 5.23% | 534,531 | - |
| 116 | OCS | Oculis Holding AG | 1.65B | 3.60% | 262,213 | 992.00K |
| 117 | INVA | Innoviva, Inc. | 1.63B | 1.07% | 650,567 | 388.52M |
| 118 | IMCR | Immunocore Holdings plc | 1.62B | 3.43% | 499,758 | 379.59M |
| 119 | SION | Sionna Therapeutics, Inc. | 1.61B | 2.68% | 439,858 | - |
| 120 | ORKA | Oruka Therapeutics, Inc. | 1.60B | 5.19% | 499,366 | - |
| 121 | QURE | uniQure N.V. | 1.60B | 4.61% | 1,728,099 | 15.75M |
| 122 | CLDX | Celldex Therapeutics, Inc. | 1.58B | 5.54% | 812,783 | 2.60M |
| 123 | GLUE | Monte Rosa Therapeutics, Inc. | 1.55B | 3.44% | 1,358,477 | 181.54M |
| 124 | AGIO | Agios Pharmaceuticals, Inc. | 1.55B | -0.15% | 1,151,601 | 44.79M |
| 125 | RLAY | Relay Therapeutics, Inc. | 1.55B | 9.45% | 3,455,673 | 8.36M |
| 126 | BHVN | Biohaven Ltd. | 1.54B | 7.81% | 2,443,071 | - |
| 127 | PGEN | Precigen, Inc. | 1.52B | 1.18% | 3,843,791 | 6.31M |
| 128 | TRVI | Trevi Therapeutics, Inc. | 1.47B | 4.62% | 1,594,633 | - |
| 129 | MANE | Veradermics, Incorporated | 1.44B | 3.55% | 178,809 | - |
| 130 | KOD | Kodiak Sciences Inc. | 1.43B | 9.66% | 748,377 | - |
| 131 | NTLA | Intellia Therapeutics, Inc. | 1.42B | 10.73% | 4,612,922 | 57.53M |
| 132 | UPB | Upstream Bio, Inc. | 1.42B | 0.77% | 517,643 | 2.80M |
| 133 | ANAB | AnaptysBio, Inc. | 1.38B | 3.82% | 501,404 | 169.47M |
| 134 | ATAI | AtaiBeckley Inc. | 1.37B | 10.56% | 4,549,762 | 3.02M |
| 135 | FTRE | Fortrea Holdings Inc. | 1.35B | 6.30% | 1,641,197 | 2.76B |
| 136 | NVAX | Novavax, Inc. | 1.34B | 4.83% | 3,250,396 | 1.06B |
| 137 | SVRA | Savara Inc. | 1.31B | 2.71% | 1,944,972 | - |
| 138 | RAPP | Rapport Therapeutics, Inc. | 1.29B | 6.30% | 301,708 | - |
| 139 | IMTX | Immatics N.V. | 1.29B | 12.37% | 480,020 | 99.45M |
| 140 | CAPR | Capricor Therapeutics, Inc. | 1.28B | 7.34% | 1,131,184 | 11.13M |
| 141 | DBVT | DBV Technologies S.A. | 1.27B | -0.93% | 352,072 | 5.50M |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | 4.54% | 2,637,248 | 6.31M |
| 143 | INBX | Inhibrx Biosciences, Inc. | 1.22B | 2.92% | 142,933 | 1.40M |
| 144 | DAWN | Day One Biopharmaceuticals, Inc. | 1.17B | 8.87% | 3,129,797 | 133.67M |
| 145 | ZBIO | Zenas BioPharma, Inc. | 1.17B | 3.76% | 864,232 | 15.00M |
| 146 | XERS | Xeris Biopharma Holdings, Inc. | 1.16B | 1.45% | 983,086 | 266.14M |
| 147 | CMPX | Compass Therapeutics, Inc. | 1.16B | 4.82% | 2,008,084 | 850.00K |
| 148 | SEPN | Septerna, Inc. | 1.14B | 3.97% | 280,135 | 22.05M |
| 149 | IVA | Inventiva S.A. | 1.13B | 1.38% | 298,236 | 19.93M |
| 150 | MLTX | MoonLake Immunotherapeutics | 1.11B | 5.01% | 861,420 | - |
| 151 | PHAR | Pharming Group N.V. | 1.11B | 0.31% | 37,972 | 362.27M |
| 152 | EYPT | EyePoint, Inc. | 1.10B | 4.48% | 870,376 | 42.34M |
| 153 | SANA | Sana Biotechnology, Inc. | 1.05B | 10.70% | 3,273,616 | - |
| 154 | TBPH | Theravance Biopharma, Inc. | 1.04B | 4.60% | 778,416 | 80.33M |
| 155 | NBTX | Nanobiotix S.A. | 1.03B | -0.86% | 6,109 | 11.93M |
| 156 | ORIC | ORIC Pharmaceuticals, Inc. | 1.01B | 4.62% | 1,987,327 | - |
| 157 | IOVA | Iovance Biotherapeutics, Inc. | 1.00B | 7.20% | 6,916,224 | 250.43M |
| 158 | VTYX | Ventyx Biosciences, Inc. | 1.00B | 0.14% | 1,462,711 | - |
| 159 | VIR | Vir Biotechnology, Inc. | 1.00B | 3.90% | 1,864,741 | 16.86M |
| 160 | URGN | UroGen Pharma Ltd. | 999.37M | 4.04% | 739,914 | 96.52M |
| 161 | AKTS | Aktis Oncology, Inc. | 996.87M | -3.01% | 245,200 | 5.56M |
| 162 | SPRY | ARS Pharmaceuticals, Inc. | 991.45M | 3.72% | 1,103,470 | 142.77M |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 984.95M | 1.37% | 950,608 | 147.19M |
| 164 | GERN | Geron Corporation | 976.68M | 4.79% | 17,924,164 | 183.40M |
| 165 | PVLA | Palvella Therapeutics, Inc. | 972.96M | 7.55% | 396,363 | - |
| 166 | CTMX | CytomX Therapeutics, Inc. | 960.70M | 8.21% | 3,595,538 | 113.63M |
| 167 | ABCL | AbCellera Biologics Inc. | 945.90M | 13.67% | 5,395,984 | 35.33M |
| 168 | GHRS | GH Research PLC | 940.68M | 11.02% | 307,309 | - |
| 169 | AVBP | ArriVent BioPharma, Inc. | 902.41M | 2.39% | 476,912 | - |
| 170 | ARVN | Arvinas, Inc. | 865.74M | 4.01% | 605,293 | 312.30M |
| 171 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 855.88M | 5.42% | 520,901 | - |
| 172 | ANNX | Annexon, Inc. | 854.09M | 1.78% | 2,060,351 | - |
| 173 | SGP | SpyGlass Pharma, Inc. | 842.45M | 65.00% | 1,195,279 | - |
| 174 | BCAX | Bicara Therapeutics Inc. | 841.45M | 1.72% | 408,722 | - |
| 175 | XNCR | Xencor, Inc. | 829.08M | 7.30% | 630,046 | 150.13M |
| 176 | VALN | Valneva SE | 825.18M | 1.71% | 47,501 | 211.09M |
| 177 | MRVI | Maravai LifeSciences Holdings, Inc. | 802.92M | 1.62% | 1,078,039 | 192.44M |
| 178 | OMER | Omeros Corporation | 796.21M | 4.56% | 1,250,869 | - |
| 179 | YDES | YD Bio Limited | 793.21M | 7.16% | 38,268 | 510.36K |
| 180 | JANX | Janux Therapeutics, Inc. | 786.13M | 7.31% | 1,769,453 | 10.00M |
| 181 | EIKN | Eikon Therapeutics, Inc. | 782.77M | -3.33% | 831,555 | - |
| 182 | MDXG | MiMedx Group, Inc. | 762.73M | 2.39% | 860,322 | 393.44M |
| 183 | KALV | KalVista Pharmaceuticals, Inc. | 753.14M | 3.47% | 1,142,317 | 1.43M |
| 184 | NKTR | Nektar Therapeutics | 748.77M | 4.81% | 416,550 | 62.60M |
| 185 | DRUG | Bright Minds Biosciences Inc. | 744.04M | 4.13% | 116,453 | - |
| 186 | MPLT | MapLight Therapeutics, Inc. | 741.03M | 8.15% | 183,503 | - |
| 187 | ABUS | Arbutus Biopharma Corporation | 738.52M | 4.63% | 2,563,274 | 14.61M |
| 188 | CGEM | Cullinan Therapeutics, Inc. | 722.50M | 3.21% | 420,129 | - |
| 189 | GYRE | Gyre Therapeutics, Inc. | 716.22M | 4.93% | 47,478 | 107.27M |
| 190 | AGMB | AgomAb Therapeutics NV | 713.99M | -8.44% | 2,362,250 | - |
| 191 | JBIO | Jade Biosciences, Inc. | 704.78M | 6.46% | 230,798 | - |
| 192 | KURA | Kura Oncology, Inc. | 681.35M | 5.81% | 1,538,942 | 104.03M |
| 193 | FULC | Fulcrum Therapeutics, Inc. | 642.55M | 1.99% | 489,194 | 80.00M |
| 194 | REPL | Replimune Group, Inc. | 639.94M | 11.83% | 1,698,587 | - |
| 195 | ENGN | enGene Holdings Inc. | 639.70M | 7.79% | 417,107 | - |
| 196 | SLS | SELLAS Life Sciences Group, Inc. | 635.15M | 5.67% | 5,470,616 | - |
| 197 | PRME | Prime Medicine, Inc. | 632.03M | 10.19% | 3,646,667 | 5.98M |
| 198 | RIGL | Rigel Pharmaceuticals, Inc. | 619.87M | 2.81% | 353,835 | 282.08M |
| 199 | ALT | Altimmune, Inc. | 609.88M | -1.02% | 3,846,002 | 20.00K |
| 200 | DRTS | Alpha Tau Medical Ltd. | 606.23M | 3.64% | 171,323 | - |
| 201 | CRMD | CorMedix Inc. | 605.89M | 4.63% | 1,574,161 | 214.30M |
| 202 | LBRX | LB Pharmaceuticals Inc | 602.62M | -0.08% | 255,873 | - |
| 203 | MGTX | MeiraGTx Holdings plc | 598.05M | 3.19% | 613,805 | 27.42M |
| 204 | DSGN | Design Therapeutics, Inc. | 585.02M | 3.12% | 246,779 | - |
| 205 | DNA | Ginkgo Bioworks Holdings, Inc. | 574.05M | 21.39% | 2,658,294 | 180.61M |
| 206 | PROK | ProKidney Corp. | 562.56M | 8.09% | 946,323 | 744.00K |
| 207 | CTNM | Contineum Therapeutics, Inc. | 547.94M | 3.59% | 423,048 | - |
| 208 | VOR | Vor Biopharma Inc. | 546.40M | 9.03% | 1,044,943 | - |
| 209 | EVMN | Evommune, Inc. | 545.68M | 3.90% | 204,958 | 13.00M |
| 210 | KROS | Keros Therapeutics, Inc. | 535.29M | 2.09% | 305,485 | 246.72M |
| 211 | LXRX | Lexicon Pharmaceuticals, Inc. | 525.31M | 4.24% | 2,084,893 | 70.86M |
| 212 | GOSS | Gossamer Bio, Inc. | 523.09M | -7.19% | 7,924,764 | 44.05M |
| 213 | RGNX | REGENXBIO Inc. | 522.94M | 0.68% | 1,004,881 | 161.32M |
| 214 | LXEO | Lexeo Therapeutics, Inc. | 522.59M | 3.92% | 1,732,831 | - |
| 215 | TENX | Tenax Therapeutics, Inc. | 516.46M | 2.99% | 128,167 | - |
| 216 | VSTM | Verastem, Inc. | 514.80M | 6.21% | 1,278,610 | 13.38M |
| 217 | SLDB | Solid Biosciences Inc. | 507.97M | 4.65% | 1,886,349 | - |
| 218 | ADCT | ADC Therapeutics SA | 496.75M | 2.56% | 1,047,408 | 75.21M |
| 219 | FBRX | Forte Biosciences, Inc. | 491.97M | -4.23% | 176,061 | - |
| 220 | ZVRA | Zevra Therapeutics, Inc. | 484.16M | 2.87% | 603,900 | 84.39M |
| 221 | LYEL | Lyell Immunopharma, Inc. | 482.45M | 0.35% | 124,585 | 41.00K |
| 222 | PRTA | Prothena Corporation plc | 479.63M | 6.65% | 581,018 | 11.79M |
| 223 | ANRO | Alto Neuroscience, Inc. | 472.83M | 7.87% | 301,584 | - |
| 224 | FDMT | 4D Molecular Therapeutics, Inc. | 458.56M | 7.15% | 778,192 | 120.00K |
| 225 | TECX | Tectonic Therapeutic, Inc. | 456.12M | 6.61% | 291,544 | - |
| 226 | KYTX | Kyverna Therapeutics, Inc. | 453.04M | 9.08% | 783,008 | - |
| 227 | IVVD | Invivyd, Inc. | 448.36M | -7.02% | 5,839,059 | 50.04M |
| 228 | VNDA | Vanda Pharmaceuticals Inc. | 447.36M | 4.70% | 932,030 | 212.07M |
| 229 | LENZ | LENZ Therapeutics, Inc. | 444.94M | 1.79% | 858,653 | 17.50M |
| 230 | ZURA | Zura Bio Limited | 442.82M | 6.00% | 452,142 | - |
| 231 | DMAC | DiaMedica Therapeutics Inc. | 436.13M | 8.75% | 164,651 | - |
| 232 | OCGN | Ocugen, Inc. | 436.09M | - | 3,749,852 | 5.37M |
| 233 | NBP | NovaBridge Biosciences | 426.58M | 11.11% | 547,203 | - |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 425.41M | -1.06% | 265,042 | - |
| 235 | PLYX | Polaryx Therapeutics, Inc. | 421.83M | -44.31% | 188,568 | - |
| 236 | NAGE | Niagen Bioscience, Inc. | 416.46M | 1.36% | 1,131,205 | 124.71M |
| 237 | PRTC | PureTech Health plc | 416.41M | -2.22% | 387 | 6.39M |
| 238 | BNTC | Benitec Biopharma Inc. | 415.17M | 4.03% | 140,152 | - |
| 239 | ASMB | Assembly Biosciences, Inc. | 414.73M | 3.27% | 56,045 | 37.19M |
| 240 | LCTX | Lineage Cell Therapeutics, Inc. | 411.96M | 1.19% | 1,080,382 | 10.82M |
| 241 | ABSI | Absci Corporation | 405.25M | 6.52% | 3,747,687 | 2.82M |
| 242 | GLSI | Greenwich LifeSciences, Inc. | 401.78M | 15.13% | 302,869 | - |
| 243 | BCYC | Bicycle Therapeutics plc | 392.62M | 6.59% | 263,186 | 28.34M |
| 244 | ENTA | Enanta Pharmaceuticals, Inc. | 392.04M | 4.16% | 164,022 | 65.32M |
| 245 | ACRS | Aclaris Therapeutics, Inc. | 386.79M | 5.31% | 1,572,786 | 15.74M |
| 246 | MNPR | Monopar Therapeutics Inc. | 385.92M | 1.72% | 326,658 | - |
| 247 | TRDA | Entrada Therapeutics, Inc. | 380.13M | 5.66% | 184,896 | 61.52M |
| 248 | ALLO | Allogene Therapeutics, Inc. | 379.79M | 3.68% | 3,960,803 | 22.00K |
| 249 | AUTL | Autolus Therapeutics plc | 377.92M | 7.58% | 1,176,641 | 51.13M |
| 250 | IMMP | Immutep Limited | 377.08M | 0.38% | 156,478 | 3.31M |
| 251 | ANL | Adlai Nortye Ltd. | 369.37M | -1.28% | 414,675 | -1.35M |
| 252 | AVXL | Anavex Life Sciences Corp. | 366.33M | 7.61% | 1,681,294 | - |
| 253 | NMRA | Neumora Therapeutics, Inc. | 360.27M | 8.16% | 1,115,258 | - |
| 254 | VTVT | vTv Therapeutics Inc. | 360.11M | -6.42% | 26,150 | 17.00K |
| 255 | TARA | Protara Therapeutics, Inc. | 356.36M | 2.31% | 615,208 | - |
| 256 | AURA | Aura Biosciences, Inc. | 355.62M | 4.48% | 221,724 | - |
| 257 | IMMX | Immix Biopharma, Inc. | 355.17M | 13.28% | 867,187 | - |
| 258 | PBYI | Puma Biotechnology, Inc. | 349.71M | 2.21% | 409,025 | 212.00M |
| 259 | RCKT | Rocket Pharmaceuticals, Inc. | 341.98M | 5.33% | 2,183,331 | - |
| 260 | FHTX | Foghorn Therapeutics Inc. | 332.74M | 8.60% | 222,214 | 24.52M |
| 261 | ALDX | Aldeyra Therapeutics, Inc. | 332.70M | 8.64% | 974,059 | - |
| 262 | AVIR | Atea Pharmaceuticals, Inc. | 324.23M | 3.36% | 323,799 | - |
| 263 | CADL | Candel Therapeutics, Inc. | 320.06M | 10.21% | 734,219 | - |
| 264 | IMRX | Immuneering Corporation | 318.33M | 9.07% | 1,576,710 | - |
| 265 | XFOR | X4 Pharmaceuticals, Inc. | 311.27M | -2.73% | 831,773 | 33.98M |
| 266 | ACIU | AC Immune SA | 310.68M | 6.08% | 315,928 | 5.48M |
| 267 | PEPG | PepGen Inc. | 307.99M | 4.43% | 587,378 | - |
| 268 | XOMA | XOMA Royalty Corporation | 307.84M | -0.24% | 400,961 | 47.11M |
| 269 | HELP | Cybin Inc. | 298.42M | 2.05% | 716,284 | - |
| 270 | RZLT | Rezolute, Inc. | 289.31M | 6.85% | 2,411,618 | - |
| 271 | LRMR | Larimar Therapeutics, Inc. | 288.44M | 9.77% | 1,091,614 | - |
| 272 | RLMD | Relmada Therapeutics, Inc. | 284.53M | 7.78% | 478,812 | - |
| 273 | ARMP | Armata Pharmaceuticals, Inc. | 280.33M | -4.70% | 36,718 | 5.05M |
| 274 | ABEO | Abeona Therapeutics Inc. | 278.00M | 4.69% | 878,700 | 400.00K |
| 275 | AARD | Aardvark Therapeutics, Inc. | 275.43M | 12.05% | 151,821 | - |
| 276 | ENLV | Enlivex Therapeutics Ltd. | 275.36M | - | 314,814 | - |
| 277 | FENC | Fennec Pharmaceuticals Inc. | 267.76M | 2.61% | 91,267 | 38.79M |
| 278 | NGNE | Neurogene Inc. | 266.89M | 5.04% | 91,235 | 925.00K |
| 279 | CLLS | Cellectis S.A. | 265.29M | 2.00% | 18,796 | 82.55M |
| 280 | AVTX | Avalo Therapeutics, Inc. | 262.70M | 7.91% | 319,370 | 192.00K |
| 281 | CLYM | Climb Bio, Inc. | 259.73M | 16.99% | 893,694 | - |
| 282 | CHRS | Coherus Oncology, Inc. | 258.66M | 2.39% | 2,444,996 | 277.73M |
| 283 | NAUT | Nautilus Biotechnology, Inc. | 256.40M | 0.50% | 154,322 | - |
| 284 | OABI | OmniAb, Inc. | 244.72M | 3.03% | 319,072 | 21.09M |
| 285 | PALI | Palisade Bio, Inc. | 244.37M | 9.33% | 2,915,748 | - |
| 286 | CABA | Cabaletta Bio, Inc. | 241.63M | 7.73% | 2,367,794 | - |
| 287 | STTK | Shattuck Labs, Inc. | 238.57M | 5.60% | 419,425 | 1.00M |
| 288 | IKT | Inhibikase Therapeutics, Inc. | 232.53M | 7.59% | 1,511,692 | 1.00 |
| 289 | PLX | Protalix BioTherapeutics, Inc. | 232.42M | -0.69% | 2,559,570 | 61.84M |
| 290 | HRTX | Heron Therapeutics, Inc. | 231.04M | 4.13% | 1,139,182 | 155.10M |
| 291 | MDWD | MediWound Ltd. | 228.09M | 3.48% | 100,916 | 20.93M |
| 292 | NVCT | Nuvectis Pharma, Inc. | 227.72M | 5.71% | 82,764 | - |
| 293 | ACHV | Achieve Life Sciences, Inc. | 226.24M | 7.59% | 576,107 | - |
| 294 | SLN | Silence Therapeutics plc | 224.36M | 5.09% | 199,597 | 25.83M |
| 295 | OBIO | Orchestra BioMed Holdings, Inc. | 220.78M | 6.20% | 149,475 | 2.82M |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 215.10M | 7.83% | 570,361 | 97.60M |
| 297 | ALEC | Alector, Inc. | 213.94M | 7.69% | 1,161,356 | 69.05M |
| 298 | CNTX | Context Therapeutics Inc. | 209.48M | 0.88% | 2,302,442 | - |
| 299 | TNXP | Tonix Pharmaceuticals Holding Corp. | 209.05M | 9.30% | 303,828 | 10.30M |
| 300 | OVID | Ovid Therapeutics Inc. | 208.29M | 10.34% | 1,578,797 | 6.61M |
| 301 | NERV | Minerva Neurosciences, Inc. | 207.72M | 13.74% | 78,031 | - |
| 302 | IRD | Opus Genetics, Inc. | 207.58M | 16.67% | 2,897,195 | 14.63M |
| 303 | VYGR | Voyager Therapeutics, Inc. | 204.61M | 3.95% | 413,872 | 31.32M |
| 304 | CAMP | Camp4 Therapeutics Corporation | 199.22M | 7.24% | 40,897 | 3.80M |
| 305 | SABS | SAB Biotherapeutics, Inc. | 198.52M | 4.77% | 383,828 | 114.70K |
| 306 | SRZN | Surrozen, Inc. | 195.43M | 5.74% | 144,404 | 3.60M |
| 307 | NTHI | NeOnc Technologies Holdings, Inc. | 190.26M | 5.74% | 75,285 | 59.99K |
| 308 | CBIO | Crescent Biopharma, Inc. | 185.92M | 1.17% | 176,739 | - |
| 309 | SLGL | Sol-Gel Technologies Ltd. | 183.25M | 1.67% | 8,166 | 18.97M |
| 310 | HUMA | Humacyte, Inc. | 181.09M | 5.88% | 2,435,426 | 1.57M |
| 311 | GALT | Galectin Therapeutics Inc. | 180.52M | -1.06% | 473,778 | - |
| 312 | SGMT | Sagimet Biosciences Inc. | 180.49M | 2.02% | 769,547 | - |
| 313 | PRLD | Prelude Therapeutics Incorporated | 178.80M | 7.43% | 221,736 | 10.50M |
| 314 | MIST | Milestone Pharmaceuticals Inc. | 178.78M | 2.33% | 1,624,601 | - |
| 315 | EDIT | Editas Medicine, Inc. | 177.67M | 9.31% | 1,930,416 | 46.38M |
| 316 | CCCC | C4 Therapeutics, Inc. | 176.38M | 6.43% | 829,230 | 30.11M |
| 317 | TNYA | Tenaya Therapeutics, Inc. | 175.69M | 8.20% | 2,532,852 | - |
| 318 | ELDN | Eledon Pharmaceuticals, Inc. | 173.78M | 11.17% | 738,072 | - |
| 319 | TLSA | Tiziana Life Sciences Ltd | 173.57M | 7.09% | 229,979 | - |
| 320 | MOLN | Molecular Partners AG | 173.54M | 1.95% | 2,111 | 856.30K |
| 321 | RNAC | Cartesian Therapeutics, Inc. | 168.76M | 3.34% | 122,821 | 1.09M |
| 322 | THAR | Tharimmune, Inc. | 163.65M | 5.34% | 1,100,341 | - |
| 323 | IPHA | Innate Pharma S.A. | 158.29M | 1.16% | 4,601 | 14.84M |
| 324 | PRQR | ProQR Therapeutics N.V. | 158.02M | 2.74% | 357,433 | 18.86M |
| 325 | CGEN | Compugen Ltd. | 156.20M | 5.03% | 296,245 | 6.90M |
| 326 | KLRS | Kalaris Therapeutics, Inc. | 155.98M | -0.12% | 44,325 | - |
| 327 | ZNTL | Zentalis Pharmaceuticals, Inc. | 154.75M | 8.14% | 841,899 | 26.87M |
| 328 | SGMO | Sangamo Therapeutics, Inc. | 148.67M | 13.15% | 9,977,393 | 32.88M |
| 329 | IPSC | Century Therapeutics, Inc. | 148.59M | 1.80% | 1,569,687 | 113.34M |
| 330 | RANI | Rani Therapeutics Holdings, Inc. | 148.26M | 10.91% | 972,409 | 1.20M |
| 331 | CRBU | Caribou Biosciences, Inc. | 146.74M | 6.08% | 1,015,727 | 9.30M |
| 332 | ELTX | Elicio Therapeutics, Inc. | 145.39M | 9.33% | 115,821 | - |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 145.38M | 6.67% | 504,762 | - |
| 334 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 145.08M | 5.95% | 195,694 | - |
| 335 | MENS | Jyong Biotech Ltd. | 143.80M | 12.65% | 502,199 | - |
| 336 | UNCY | Unicycive Therapeutics, Inc. | 143.78M | 8.08% | 599,172 | - |
| 337 | NKTX | Nkarta, Inc. | 143.48M | 5.21% | 607,373 | - |
| 338 | VXRT | Vaxart, Inc. | 142.63M | -4.60% | - | 148.20M |
| 339 | CBUS | Cibus, Inc. | 140.52M | -7.14% | 586,914 | 3.79M |
| 340 | SPRO | Spero Therapeutics, Inc. | 136.34M | 5.22% | 1,027,764 | 40.55M |
| 341 | CNTB | Connect Biopharma Holdings Limited | 135.85M | 7.39% | 70,891 | 762.00K |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 135.73M | 5.25% | 167,214 | 2.00M |
| 343 | STRO | Sutro Biopharma, Inc. | 132.22M | 6.30% | 108,980 | 105.65M |
| 344 | FATE | Fate Therapeutics, Inc. | 131.50M | 8.57% | 1,501,246 | 7.14M |
| 345 | WHWK | Whitehawk Therapeutics, Inc. | 130.07M | 1.85% | 106,248 | 14.38M |
| 346 | BDTX | Black Diamond Therapeutics, Inc. | 128.48M | 4.40% | 710,841 | 70.00M |
| 347 | MCRB | Seres Therapeutics, Inc. | 126.29M | 4.18% | 63,893 | 351.00K |
| 348 | ADAG | Adagene Inc. | 123.96M | 3.54% | 294,500 | 103.20K |
| 349 | CDXS | Codexis, Inc. | 120.13M | 4.72% | 1,202,196 | 52.93M |
| 350 | KRRO | Korro Bio, Inc. | 118.38M | 8.93% | 184,747 | 7.37M |
| 351 | KPTI | Karyopharm Therapeutics Inc. | 114.62M | 2.79% | 520,560 | 142.53M |
| 352 | MGNX | MacroGenics, Inc. | 114.50M | 6.18% | 793,839 | 127.63M |
| 353 | INO | Inovio Pharmaceuticals, Inc. | 114.05M | 6.41% | 1,235,518 | 182.34K |
| 354 | COYA | Coya Therapeutics, Inc. | 113.48M | 9.50% | 110,275 | 3.99M |
| 355 | TTRX | Turn Therapeutics Inc. | 113.36M | 4.05% | 12,525 | - |
| 356 | ALXO | ALX Oncology Holdings Inc. | 111.15M | -0.49% | 706,706 | - |
| 357 | ACOG | Alpha Cognition Inc. | 110.88M | 13.33% | 28,635 | 7.43M |
| 358 | VRCA | Verrica Pharmaceuticals Inc. | 110.49M | 4.54% | 124,240 | 30.83M |
| 359 | CRDF | Cardiff Oncology, Inc. | 107.78M | 8.11% | 926,830 | 501.00K |
| 360 | GNLX | Genelux Corporation | 105.84M | 1.70% | 254,541 | 8.00K |
| 361 | ACTU | Actuate Therapeutics, Inc. | 102.50M | 2.08% | 22,092 | - |
| 362 | DWTX | Dogwood Therapeutics, Inc. | 101.70M | - | 12,581 | - |
| 363 | FBIO | Fortress Biotech, Inc. | 101.49M | 11.60% | 627,388 | 62.30M |
| 364 | SEER | Seer, Inc. | 100.69M | 2.86% | 87,608 | 16.38M |
| 365 | VANI | Vivani Medical, Inc. | 100.62M | 2.44% | 221,872 | - |
| 366 | AGEN | Agenus Inc. | 99.98M | 6.14% | 490,205 | 106.83M |
| 367 | ARTV | Artiva Biotherapeutics, Inc. | 98.92M | 4.13% | 145,051 | 251.00K |
| 368 | ANIX | Anixa Biosciences, Inc. | 98.80M | 7.64% | 132,513 | - |
| 369 | SAVA | Cassava Sciences, Inc. | 98.07M | 7.41% | 584,809 | - |
| 370 | NBY | NovaBay Pharmaceuticals, Inc. | 97.72M | 1.10% | 1,772,793 | 10.30M |
| 371 | ONCY | Oncolytics Biotech Inc. | 95.33M | 5.89% | 1,461,944 | - |
| 372 | PYXS | Pyxis Oncology, Inc. | 94.02M | -1.95% | 1,031,017 | 2.82M |
| 373 | CGTX | Cognition Therapeutics, Inc. | 93.57M | 6.03% | 973,715 | - |
| 374 | EQ | Equillium, Inc. | 92.56M | 2.70% | 742,703 | 4.39M |
| 375 | CSBR | Champions Oncology, Inc. | 91.79M | 1.23% | 3,349 | 58.42M |
| 376 | DTIL | Precision BioSciences, Inc. | 91.47M | 6.44% | 91,637 | 698.00K |
| 377 | EXOZ | eXoZymes, Inc. | 88.29M | -3.13% | 902 | -700.00 |
| 378 | ATYR | aTyr Pharma, Inc. | 88.09M | 10.89% | 1,629,398 | 190.00K |
| 379 | BMEA | Biomea Fusion, Inc. | 86.26M | 7.02% | 1,187,788 | - |
| 380 | IBIO | iBio, Inc. | 78.75M | 12.56% | 2,118,875 | 500.00K |
| 381 | MNOV | MediciNova, Inc. | 78.63M | - | 54,154 | 257.92K |
| 382 | OKYO | OKYO Pharma Limited | 77.87M | 1.05% | 65,174 | - |
| 383 | SPRB | Spruce Biosciences, Inc. | 77.49M | 2.19% | 29,946 | 697.00K |
| 384 | MAIA | MAIA Biotechnology, Inc. | 75.38M | 3.14% | 546,822 | - |
| 385 | PYPD | PolyPid Ltd. | 75.19M | 3.91% | 37,304 | - |
| 386 | IMUX | Immunic, Inc. | 74.58M | 5.26% | 1,192,032 | - |
| 387 | IMA | ImageneBio, Inc. | 73.60M | 0.07% | 95,337 | 800.00K |
| 388 | HYFT | MindWalk Holdings Corp. | 73.31M | 11.35% | 318,460 | 19.02M |
| 389 | XBIT | XBiotech Inc. | 72.26M | 3.04% | 19,957 | - |
| 390 | ACET | Adicet Bio, Inc. | 71.05M | 9.16% | 226,294 | - |
| 391 | PTHS | Pelthos Therapeutics Inc. | 70.96M | -1.42% | 6,392 | 7.41M |
| 392 | PLRX | Pliant Therapeutics, Inc. | 70.05M | 4.59% | 715,040 | - |
| 393 | ATHE | Alterity Therapeutics Limited | 68.61M | 10.66% | 29,067 | 3.57M |
| 394 | MREO | Mereo BioPharma Group plc | 67.55M | 13.20% | 4,389,131 | 500.00K |
| 395 | GANX | Gain Therapeutics, Inc. | 67.31M | 8.02% | 691,861 | - |
| 396 | ANVS | Annovis Bio, Inc. | 65.99M | 2.05% | 550,923 | - |
| 397 | ETHZ | ETHZilla Corporation | 65.78M | 11.61% | 852,622 | 4.11M |
| 398 | COEP | Coeptis Therapeutics Holdings, Inc. | 64.01M | 6.22% | 72,059 | 501.00K |
| 399 | GUTS | Fractyl Health, Inc. | 63.65M | 3.75% | 6,046,383 | 3.00K |
| 400 | KZIA | Kazia Therapeutics Limited | 63.09M | 3.02% | 102,343 | 1.20M |
| 401 | BYSI | BeyondSpring Inc. | 61.68M | -2.60% | 32,903 | 1.88M |
| 402 | ESLA | Estrella Immunopharma, Inc. | 60.95M | 9.85% | 1,080,182 | - |
| 403 | IFRX | InflaRx N.V. | 60.63M | 8.42% | 638,596 | 73.73K |
| 404 | TCRX | TScan Therapeutics, Inc. | 58.45M | 13.14% | 1,084,774 | 8.42M |
| 405 | MGX | Metagenomi Therapeutics, Inc. | 57.82M | 9.22% | 443,832 | 30.91M |
| 406 | NRXP | NRx Pharmaceuticals, Inc. | 56.55M | 13.69% | 527,239 | 242.00K |
| 407 | ICCC | ImmuCell Corporation | 56.45M | 2.13% | 7,768 | 27.77M |
| 408 | GRCE | Grace Therapeutics, Inc. | 55.71M | 3.45% | 55,077 | - |
| 409 | PMVP | PMV Pharmaceuticals, Inc. | 55.34M | 1.96% | 208,246 | - |
| 410 | TVGN | Tevogen Bio Holdings Inc. | 55.34M | -1.96% | 497,930 | - |
| 411 | CING | Cingulate Inc. | 55.32M | 18.64% | 535,663 | - |
| 412 | NTRB | Nutriband Inc. | 52.88M | 0.12% | 12,736 | 2.28M |
| 413 | ACRV | Acrivon Therapeutics, Inc. | 52.70M | 4.37% | 619,632 | - |
| 414 | TIL | Instil Bio, Inc. | 52.63M | 4.16% | 92,758 | - |
| 415 | RADX | Radiopharm Theranostics Limited | 52.18M | 2.26% | 70,509 | 8.20M |
| 416 | QTTB | Q32 Bio Inc. | 52.17M | 9.56% | 411,342 | - |
| 417 | INKT | MiNK Therapeutics, Inc. | 51.49M | -0.45% | 12,699 | - |
| 418 | LIMN | Liminatus Pharma, Inc. | 49.80M | -10.24% | 48,782,050 | - |
| 419 | IBO | Impact BioMedical Inc. | 49.35M | -2.98% | 49,987 | 25.00K |
| 420 | CRVO | CervoMed Inc. | 49.13M | 16.09% | 105,761 | 6.16M |
| 421 | OSTX | OS Therapies Incorporated | 47.89M | 7.09% | 631,067 | - |
| 422 | ENTX | Entera Bio Ltd. | 47.69M | -11.11% | 356,052 | 124.00K |
| 423 | LPCN | Lipocine Inc. | 47.14M | 9.97% | 120,721 | 4.32M |
| 424 | NRXS | NeurAxis, Inc. | 46.34M | - | 23,138 | 3.36M |
| 425 | ATOS | Atossa Therapeutics, Inc. | 45.99M | 0.19% | 156,117 | - |
| 426 | PSTV | Plus Therapeutics, Inc. | 45.98M | 11.12% | 8,485,036 | 5.26M |
| 427 | ALGS | Aligos Therapeutics, Inc. | 45.04M | 12.79% | 78,020 | 2.65M |
| 428 | KZR | Kezar Life Sciences, Inc. | 44.82M | 1.49% | 16,928 | - |
| 429 | LONA | LeonaBio, Inc. | 42.76M | -4.38% | 33,478 | - |
| 430 | CVM | CEL-SCI Corporation | 42.04M | 2.04% | 40,432 | - |
| 431 | APLM | Apollomics, Inc. | 41.31M | 3.49% | 22,562 | 6.93M |
| 432 | ABVC | ABVC BioPharma, Inc. | 41.01M | 8.75% | 77,141 | 797.92K |
| 433 | GLTO | Galecto, Inc. | 40.35M | 11.62% | 48,873 | - |
| 434 | INMB | INmune Bio Inc. | 40.14M | 6.34% | 320,197 | 50.00K |
| 435 | LSTA | Lisata Therapeutics, Inc. | 40.05M | -1.30% | 127,837 | 1.07M |
| 436 | TELO | Telomir Pharmaceuticals, Inc. | 39.54M | 2.68% | 120,080 | - |
| 437 | PDSB | PDS Biotechnology Corporation | 39.13M | 3.59% | 449,897 | - |
| 438 | LITS | Lite Strategy, Inc. | 38.98M | 13.55% | 512,166 | - |
| 439 | NXTC | NextCure, Inc. | 38.91M | 0.09% | 4,384 | - |
| 440 | HURA | TuHURA Biosciences, Inc. | 38.19M | 42.95% | 2,305,067 | - |
| 441 | JSPR | Jasper Therapeutics, Inc. | 37.78M | 6.30% | 526,787 | - |
| 442 | CELU | Celularity Inc. | 37.78M | 11.97% | 16,480 | 40.58M |
| 443 | VERU | Veru Inc. | 37.56M | 4.46% | 65,874 | 16.89M |
| 444 | XLO | Xilio Therapeutics, Inc. | 36.53M | 4.04% | 454,194 | 31.80M |
| 445 | RNXT | RenovoRx, Inc. | 36.28M | 4.11% | 308,527 | 928.00K |
| 446 | GBIO | Generation Bio Co. | 36.04M | -6.97% | 551,924 | 15.27M |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 35.88M | -0.86% | 93,969 | 90.00K |
| 448 | ATRA | Atara Biotherapeutics, Inc. | 35.19M | 8.20% | 99,919 | 151.93M |
| 449 | TVRD | Tvardi Therapeutics, Inc. | 34.90M | 4.79% | 100,750 | - |
| 450 | HYPD | Hyperion DeFi, Inc. | 34.77M | 19.65% | 956,079 | 345.32K |
| 451 | PLUR | Pluri Inc. | 34.62M | -4.93% | 17,501 | 1.33M |
| 452 | OKUR | OnKure Therapeutics, Inc. | 33.87M | 7.76% | 88,886 | - |
| 453 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 33.48M | 12.35% | 3,540,856 | - |
| 454 | KYNB | Kyntra Bio, Inc. | 33.25M | 9.60% | 17,238 | 8.30M |
| 455 | OTLK | Outlook Therapeutics, Inc. | 31.56M | 10.10% | 1,204,175 | 1.41M |
| 456 | DYAI | Dyadic International, Inc. | 31.23M | 1.58% | 33,601 | 3.34M |
| 457 | NRSN | NeuroSense Therapeutics Ltd. | 31.12M | 8.03% | 152,051 | - |
| 458 | PASG | Passage Bio, Inc. | 30.23M | 4.39% | 77,400 | - |
| 459 | RNTX | Rein Therapeutics Inc. | 29.93M | -0.13% | 101,688 | - |
| 460 | ANTX | AN2 Therapeutics, Inc. | 29.87M | 2.83% | 68,798 | - |
| 461 | HOWL | Werewolf Therapeutics, Inc. | 29.72M | 1.02% | 205,281 | 1.14M |
| 462 | LTRN | Lantern Pharma Inc. | 29.53M | 3.13% | 45,492 | - |
| 463 | CUE | Cue Biopharma, Inc. | 29.21M | 1.27% | 379,661 | 7.10M |
| 464 | PTN | Palatin Technologies, Inc. | 28.95M | -2.06% | 9,484 | 8.85M |
| 465 | BRNS | Barinthus Biotherapeutics plc | 28.79M | -5.06% | 27,482 | 14.97M |
| 466 | EVAX | Evaxion A/S | 28.02M | 15.46% | 62,268 | 7.65M |
| 467 | MRKR | Marker Therapeutics, Inc. | 27.51M | -0.60% | 231,873 | 4.69M |
| 468 | PMN | ProMIS Neurosciences, Inc. | 27.40M | -2.82% | 61,411 | - |
| 469 | AEON | AEON Biopharma, Inc. | 26.43M | 2.80% | 73,113 | - |
| 470 | SKYE | Skye Bioscience, Inc. | 26.26M | 2.48% | 200,896 | - |
| 471 | BOLD | Boundless Bio, Inc. | 25.97M | 6.42% | 285,016 | - |
| 472 | BCTX | BriaCell Therapeutics Corp. | 25.95M | 0.24% | 195,524 | - |
| 473 | LIXT | Lixte Biotechnology Holdings, Inc. | 25.70M | -2.32% | 78,774 | - |
| 474 | XCUR | Exicure, Inc. | 25.69M | -5.40% | 107,168 | 500.00K |
| 475 | SER | Serina Therapeutics, Inc. | 25.56M | -4.05% | 350,019 | 116.00K |
| 476 | IOBT | IO Biotech, Inc. | 25.18M | 9.27% | 6,919,303 | - |
| 477 | RLYB | Rallybio Corporation | 25.08M | 2.13% | 82,748 | 674.00K |
| 478 | SNTI | Senti Biosciences, Inc. | 24.46M | 13.15% | 220,063 | - |
| 479 | DARE | Daré Bioscience, Inc. | 24.15M | 0.60% | 64,695 | -57.13K |
| 480 | IGC | IGC Pharma, Inc. | 23.99M | 0.81% | 438,447 | 1.11M |
| 481 | VTGN | Vistagen Therapeutics, Inc. | 22.24M | 11.52% | 1,739,802 | 721.00K |
| 482 | NEUP | Neuphoria Therapeutics Inc. | 21.56M | 0.88% | 23,268 | 15.65M |
| 483 | INTS | Intensity Therapeutics, Inc. | 20.96M | 3.01% | 506,657 | - |
| 484 | JUNS | Jupiter Neurosciences, Inc. | 20.64M | -2.65% | 97,257 | - |
| 485 | ANEB | Anebulo Pharmaceuticals, Inc. | 20.56M | -39.05% | 793,174 | - |
| 486 | PLRZ | Polyrizon Ltd. | 20.47M | 3.34% | 67,997 | - |
| 487 | INAB | IN8bio, Inc. | 19.43M | 4.74% | 36,802 | - |
| 488 | CASI | CASI Pharmaceuticals, Inc. | 19.00M | -2.66% | 17,360 | 26.85M |
| 489 | NNVC | NanoViricides, Inc. | 18.98M | 3.53% | 250,963 | - |
| 490 | VYNE | VYNE Therapeutics Inc. | 18.63M | 1.12% | 183,733 | 524.00K |
| 491 | LEXX | Lexaria Bioscience Corp. | 18.04M | 9.52% | 334,496 | 522.00K |
| 492 | KLTO | Klotho Neurosciences, Inc. | 17.66M | 8.84% | 605,188 | - |
| 493 | GNTA | Genenta Science S.p.A. | 17.15M | -0.79% | 359,895 | - |
| 494 | FBLG | FibroBiologics, Inc. | 16.74M | 10.83% | 727,088 | - |
| 495 | KTTA | Pasithea Therapeutics Corp. | 16.74M | -4.82% | 327,082 | - |
| 496 | QNTM | Quantum BioPharma Ltd. | 16.02M | 7.14% | 105,458 | - |
| 497 | ITRM | Iterum Therapeutics plc | 15.96M | 5.89% | 218,542 | 390.00K |
| 498 | LNAI | Lunai Bioworks Inc. | 15.78M | 4.13% | 157,001 | - |
| 499 | CTXR | Citius Pharmaceuticals, Inc. | 15.67M | 6.00% | 476,857 | - |
| 500 | TRAW | Traws Pharma, Inc. | 15.66M | 13.95% | 110,554 | 2.85M |
| 501 | GTBP | GT Biopharma, Inc. | 14.36M | 8.54% | 989,202 | - |
| 502 | OSRH | OSR Holdings, Inc. | 14.12M | 6.94% | 431,249 | -90.52K |
| 503 | GDTC | CytoMed Therapeutics Limited | 13.50M | 8.33% | 816,896 | 573.19K |
| 504 | BCAB | BioAtla, Inc. | 13.49M | 10.78% | 3,003,348 | 11.00M |
| 505 | COCP | Cocrystal Pharma, Inc. | 13.37M | 12.75% | 109,251 | - |
| 506 | ALLR | Allarity Therapeutics, Inc. | 13.36M | 2.56% | 171,265 | - |
| 507 | CVKD | Cadrenal Therapeutics, Inc. | 13.33M | 6.74% | 45,431 | - |
| 508 | CRIS | Curis, Inc. | 13.32M | 13.11% | 521,583 | 11.65M |
| 509 | MBRX | Moleculin Biotech, Inc. | 13.27M | 10.23% | 158,199 | - |
| 510 | BCDA | BioCardia, Inc. | 13.27M | 0.81% | 92,253 | 3.00K |
| 511 | CLRB | Cellectar Biosciences, Inc. | 12.89M | 7.80% | 46,117 | - |
| 512 | KAPA | Kairos Pharma, Ltd. | 12.81M | 4.24% | 101,308 | - |
| 513 | NCEL | NewcelX Ltd. | 12.63M | 4.92% | 14,881 | - |
| 514 | BLRX | BioLineRx Ltd. | 12.60M | 2.05% | 4,894 | 12.74M |
| 515 | HOTH | Hoth Therapeutics, Inc. | 12.54M | 4.95% | 135,753 | - |
| 516 | KALA | KALA BIO, Inc. | 12.43M | 10.28% | 2,107,673 | - |
| 517 | TPST | Tempest Therapeutics, Inc. | 11.83M | 7.62% | 82,312 | - |
| 518 | SNGX | Soligenix, Inc. | 11.40M | 8.65% | 149,617 | 2.34K |
| 519 | SNSE | Sensei Biotherapeutics, Inc. | 11.18M | -0.45% | 14,883 | - |
| 520 | IMNN | Imunon, Inc. | 11.12M | 6.51% | 72,450 | - |
| 521 | BOLT | Bolt Biotherapeutics, Inc. | 11.08M | 6.85% | 30,768 | 5.20M |
| 522 | LGVN | Longeveron Inc. | 10.94M | 0.39% | 81,211 | 1.44M |
| 523 | AKTX | Akari Therapeutics, Plc | 10.64M | 4.44% | 167,110 | - |
| 524 | CLGN | CollPlant Biotechnologies Ltd. | 10.22M | 6.65% | 290,592 | 2.48M |
| 525 | PHIO | Phio Pharmaceuticals Corp. | 9.90M | 7.39% | 123,557 | - |
| 526 | GRDX | GridAI Technologies Corp. | 9.78M | -7.03% | 129,332 | - |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 9.42M | 5.54% | 33,155 | - |
| 528 | EDSA | Edesa Biotech, Inc. | 9.33M | - | 53,105 | - |
| 529 | EVGN | Evogene Ltd. | 9.25M | -1.82% | 171,851 | 8.02M |
| 530 | NCNA | NuCana plc | 9.24M | 6.22% | 62,493 | - |
| 531 | BRTX | BioRestorative Therapies, Inc. | 9.23M | 1.96% | 42,133 | 383.40K |
| 532 | PULM | Pulmatrix, Inc. | 9.06M | -0.40% | 8,913 | 3.00K |
| 533 | ICU | SeaStar Medical Holding Corporation | 8.94M | 2.90% | 52,533 | 881.00K |
| 534 | XTLB | XTL Biopharmaceuticals Ltd. | 8.83M | 0.94% | 38,290 | 968.00K |
| 535 | CALC | CalciMedica, Inc. | 8.65M | -1.77% | 569,426 | - |
| 536 | BIVI | BioVie Inc. | 8.52M | 6.60% | 194,742 | - |
| 537 | RNAZ | TransCode Therapeutics, Inc. | 8.17M | -10.63% | 161,956 | - |
| 538 | KPRX | Kiora Pharmaceuticals, Inc. | 7.89M | 1.42% | 45,975 | 20.00K |
| 539 | TOVX | Theriva Biologics, Inc. | 7.85M | 10.06% | 2,372,324 | - |
| 540 | REVB | Revelation Biosciences, Inc. | 7.83M | 12.24% | 720,895 | - |
| 541 | QNCX | Quince Therapeutics, Inc. | 7.75M | -4.79% | 4,948,591 | - |
| 542 | ALZN | Alzamend Neuro, Inc. | 7.53M | 5.88% | 72,283 | - |
| 543 | ADXN | Addex Therapeutics Ltd | 7.51M | - | 2,412 | 198.82K |
| 544 | PMCB | PharmaCyte Biotech, Inc. | 7.51M | 5.89% | 97,625 | - |
| 545 | IMRN | Immuron Limited | 6.85M | 3.31% | 25,841 | 4.78M |
| 546 | CELZ | Creative Medical Technology Holdings, Inc. | 6.74M | 8.43% | 37,492 | 6.00K |
| 547 | APVO | Aptevo Therapeutics Inc. | 6.69M | 11.48% | 50,947 | - |
| 548 | APM | Aptorum Group Limited | 6.58M | 9.06% | 30,657 | - |
| 549 | CLDI | Calidi Biotherapeutics, Inc. | 6.31M | 2.36% | 34,092 | - |
| 550 | PHGE | BiomX Inc. | 6.26M | -13.82% | 62,244 | - |
| 551 | QNRX | Quoin Pharmaceuticals, Ltd. | 5.99M | -8.70% | 17,485 | - |
| 552 | PPBT | Purple Biotech Ltd | 5.98M | 0.77% | 123,974 | - |
| 553 | VIVS | VivoSim Labs, Inc. | 5.95M | -11.97% | 182,818 | 140.00K |
| 554 | TCRT | Alaunos Therapeutics, Inc. | 5.87M | 12.39% | 21,107 | 6.00K |
| 555 | MTVA | MetaVia Inc. | 5.84M | 5.20% | 227,913 | - |
| 556 | MBIO | Mustang Bio, Inc. | 5.75M | 10.53% | 453,187 | - |
| 557 | CANF | Can-Fite BioPharma Ltd. | 5.56M | -2.12% | 56,346 | 560.00K |
| 558 | BGMS | Bio Green Med Solution, Inc. | 5.44M | 33.73% | 2,532,991 | 81.00K |
| 559 | PCSA | Processa Pharmaceuticals, Inc. | 5.39M | 9.68% | 58,180 | - |
| 560 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 5.35M | 8.05% | 101,714 | 1.36M |
| 561 | ACXP | Acurx Pharmaceuticals, Inc. | 5.14M | 6.31% | 44,346 | - |
| 562 | GNPX | Genprex, Inc. | 5.10M | 12.24% | 283,020 | - |
| 563 | SLXN | Silexion Therapeutics Corp | 5.03M | 6.62% | 22,904 | - |
| 564 | DCOY | Decoy Therapeutics Inc. | 4.98M | 25.79% | 617,468 | - |
| 565 | APRE | Aprea Therapeutics, Inc. | 4.83M | 10.51% | 525,391 | 488.24K |
| 566 | XBIO | Xenetic Biosciences, Inc. | 4.77M | - | 10,430 | 2.86M |
| 567 | GOVX | GeoVax Labs, Inc. | 4.59M | 3.49% | 67,293 | 3.35M |
| 568 | DRMA | Dermata Therapeutics, Inc. | 4.37M | 3.39% | 183,973 | - |
| 569 | CYCN | Cyclerion Therapeutics, Inc. | 4.19M | -0.46% | 76,311 | 2.86M |
| 570 | SILO | Silo Pharma, Inc. | 4.08M | 6.83% | 94,229 | 72.10K |
| 571 | ABP | Abpro Holdings, Inc. | 4.07M | - | 23,762 | 183.00K |
| 572 | INDP | Indaptus Therapeutics, Inc. | 4.04M | 16.13% | 49,267 | - |
| 573 | ASBP | Aspire Biopharma Holdings, Inc. | 3.92M | 10.61% | 207,063 | 1.94K |
| 574 | MLEC | Moolec Science SA | 3.90M | -6.61% | 15,110 | 7.83M |
| 575 | MTNB | Matinas BioPharma Holdings, Inc. | 3.78M | 3.15% | 15,130 | - |
| 576 | GLMD | Galmed Pharmaceuticals Ltd. | 3.64M | 11.58% | 176,466 | - |
| 577 | ADIL | Adial Pharmaceuticals, Inc. | 3.47M | - | 164,912 | - |
| 578 | GRI | GRI Bio, Inc. | 3.45M | 9.13% | 163,646 | - |
| 579 | ENVB | Enveric Biosciences, Inc. | 3.30M | -9.89% | 84,345 | - |
| 580 | LYRA | Lyra Therapeutics, Inc. | 3.23M | 2.82% | 21,760 | 600.00K |
| 581 | PBM | Psyence Biomedical Ltd. | 3.20M | 8.30% | 104,380 | - |
| 582 | OGEN | Oragenics, Inc. | 3.12M | 12.67% | 167,309 | - |
| 583 | JAGX | Jaguar Health, Inc. | 3.04M | 13.12% | 523,023 | 11.79M |
| 584 | SPRC | SciSparc Ltd. | 2.98M | 11.75% | 100,370 | 1.31M |
| 585 | ARTL | Artelo Biosciences, Inc. | 2.97M | 7.30% | 23,417 | - |
| 586 | XRTX | XORTX Therapeutics Inc. | 2.96M | -0.69% | 153,231 | - |
| 587 | ERNA | Ernexa Therapeutics Inc. | 2.95M | -44.66% | 3,926,593 | 1,000.00 |
| 588 | SCNI | Scinai Immunotherapeutics Ltd. | 2.88M | -2.01% | 18,414 | 1.15M |
| 589 | HCWB | HCW Biologics Inc. | 2.81M | 5.05% | 42,774 | 422.03K |
| 590 | CNSP | CNS Pharmaceuticals, Inc. | 2.80M | -0.88% | 22,997 | - |
| 591 | PPCB | Propanc Biopharma, Inc. | 2.54M | -5.99% | 2,092,399 | - |
| 592 | BBLG | Bone Biologics Corporation | 2.51M | 2.56% | 28,382 | - |
| 593 | CDIO | Cardio Diagnostics Holdings, Inc. | 2.36M | 22.86% | 344,973 | 15.78K |
| 594 | AZTR | Azitra, Inc. | 2.23M | -0.72% | 1,503,111 | 7.50K |
| 595 | ELAB | PMGC Holdings Inc. | 2.09M | 10.00% | 301,282 | 285.95K |
| 596 | CDT | CDT Equity Inc. | 2.06M | 10.89% | 166,504 | - |
| 597 | CMND | Clearmind Medicine Inc. | 2.02M | -6.90% | 7,289,449 | - |
| 598 | ONCO | Onconetix, Inc. | 1.82M | -4.10% | 74,798 | 1.22M |
| 599 | VRAX | Virax Biolabs Group Limited | 1.68M | 2.03% | 185,441 | 2.99K |
| 600 | ENSC | Ensysce Biosciences, Inc. | 1.68M | 0.52% | 264,135 | 4.49M |
| 601 | ADTX | Aditxt, Inc. | 1.16M | 4.54% | 229,227 | 5.95K |
| 602 | BDRX | Biodexa Pharmaceuticals Plc | 1.04M | -4.62% | 122,516 | 104.90K |